Enfermedad de Alzheimer y otros trastornos cognitivos
Publicaciones destacadas
-
Design and validation of the 1-week memory battery for assessing episodic memory and accelerated long-term forgetting in cognitively unimpaired subjects
Rami, L; León, M; Valech, N; Coll-Padrós, N; Bosch, B;(...)Salinero, A; Pérez-Millan, A; Molinuevo, JL; Sánchez-Valle, R; Tort-Merino, A.Referencia:Neuropsychology 2023.
-
Classifying Alzheimer's disease and frontotemporal dementia using machine learning with cross-sectional and longitudinal magnetic resonance imaging data
Pérez-Millan, A; Contador, J; Junc-Parella, J; Bosch, B; Borrell, L;(...)Rami, L; Balasa, M; Llad, A; Sánchez-Valle, R; Sala-Llonch, R.Referencia:Human Brain Mapping 2023.
-
The APOE4 effect: Structural brain differences in Alzheimer's disease according to the age at symptom onset
Forno, G; Contador, J; Pérez-Millan, A; Guillen, N; Falgàs, N;(...)Antonell, A; Sala-Llonch, R; Sanchez-Valle, R; Hornberger, M; Lladó, A.Referencia:European Journal Of Neurology 2023.
-
Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study
Pérez-Millan, A; Borrego-Écija, S; van Swieten, JC; Jiskoot, L; Moreno, F;(...)Seelaar, H; Langheinrich, T; Rohrer, JD; Sala-Llonch, R; Sánchez-Valle, R.Referencia:Journal Of Neurology 2023.
-
Diagnostic Performance and Clinical Applicability of Blood-Based Biomarkers in a Prospective Memory Clinic Cohort
Sarto, J; Ruiz-Garcia, R; Guillén, N; Ramos-Campoy, O; Falgàs, N;(...)Augé, JM; Naranjo, L; Sanchez-Valle, R; Lladó, A; Balasa, M.Referencia:Neurology 2023.
-
Sex differences in early-onset Alzheimer's disease
Contador, J; Pérez-Millan, A; Guillén, N; Sarto, J; Tort-Merino, A;(...)Antonell, A; Bargalló, N; Sanchez-Valle, R; Sala-Llonch, R; Lladó, A.Referencia:European Journal Of Neurology 2022.
-
Temporal order of clinical and biomarker changes in familial frontotemporal dementia
Staffaroni, AM; Quintana, M; Wendelberger, B; Heuer, HW; Russell, LL;(...)Kornak, J; Boeve, BF; Rosen, HJ; Rohrer, JD; Boxer, AL.Referencia:Nature Medicine 2022.
-
CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome
Guasp, M; Munoz-Sanchez, G; Martinez-Hernandez, E; Santana, D; Carbayo, A;(...)Framil, M; Saiz, A; Balasa, M; Ruiz-Garcia, R; Sanchez-Valle, R.Referencia:Frontiers In Immunology 2022.
-
Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias
Antonell, A; Tort-Merino, A; Balasa, M; Borrego-Écija, S; Muñoz-García, C;(...)Sánchez-Valle, R; Ríos, J; Auge, JM; Blennow, K; Zetterberg, H.Referencia:Alzheimers & Dementia 2020.